Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CYB5B mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CYB5B mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CYB5B mRNA | affects expression | 16483693
|
D003024 |
Clozapine |
Clozapine results in increased expression of CYB5B mRNA | increases expression | 19441803
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CYB5B mRNA | decreases expression | 20106945
|
C012279 |
dibutylnitrosamine |
[CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to dibutylnitrosamine | affects cotreatment|increases response to substance | 11733072
|
D004052 |
Diethylnitrosamine |
[CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Diethylnitrosamine | affects cotreatment|increases response to substance | 11733072
|
D004128 |
Dimethylnitrosamine |
[CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Dimethylnitrosamine | affects cotreatment|increases response to substance | 11733072
|
C056933 |
fumonisin B1 |
fumonisin B1 results in decreased expression of CYB5B mRNA | decreases expression | 16221962
|
D008694 |
Methamphetamine |
Methamphetamine results in increased expression of CYB5B mRNA | increases expression | 19149911
|
D009602 |
Nitrosamines |
[CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to Nitrosamines | affects cotreatment|increases response to substance | 11733072
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of CYB5B mRNA | increases expression | 17616710
|
C013161 |
N-nitroso(di-n-propyl)amine |
[CYP2E1 protein co-treated with POR protein co-treated with CYB5B protein] results in increased susceptibility to N-nitroso(di-n-propyl)amine | affects cotreatment|increases response to substance | 11733072
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of CYB5B mRNA | increases expression | 18301758 15302862
|
D011374 |
Progesterone |
Progesterone results in increased expression of CYB5B mRNA | increases expression | 18070364
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of CYB5B mRNA | decreases expression | 12734198
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of CYB5B mRNA | increases expression | 16917069
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.10 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
2.88 | 16033868 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.92 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
6.92 | 19555203 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.07 | 18056438 19061943 17620307 17162532 19052882 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.07 | 16434500 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.04 | 14617031 16160616 12649775 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.08 | 18759972 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.84 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.13 | 19483382 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.34 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.24 | 15845082 15665606 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.25 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.25 | 15562024 16175315 17614352 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
4.00 | 19555203 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.50 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.50 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.50 | 18056438 19052882 16502159 3084413 16328049 17761372 18691550 17055752 19208518 20935162 16569478 19919837 20432363 19335982 16681979 20214788 20727157 18393292 20007298 20514400 16830150 19171122 19418558 10672840 10737359 16878318 18785209 17978847 18665156 3581430 19822196 18788625 16540662 18506893 11831363 17138121 16779866 17173139 21159647 17428255 18971187 19701751 16807293 19519916 20084675 16288022 18494052 16935385 19383236 19539802 19107877 19394651 16698587 18210153 20101231 17162532 20512989 18978308 20524982 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.44 | 12391285 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
2.94 | 16033868 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.57 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.56 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.56 | 17174075 21159647 7505956 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.67 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.70 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.70 | 19176532 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.95 | 17123785 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.00 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.41 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.68 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.68 | 20387270 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.48 | 17187935 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.55 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
15.21 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
15.21 | 10663392 19416960 16781746 11287661 14725611 11834606 14550746 16227642 19739265 14986274 11529661 10915739 10774834 12705907 17562736 12958197 2444490 16109766 19085960 17522070 16081117 11421492 15619225 18071297 19923254 11461765 12540782 17906064 12594235 11739529 16393943 19370779 18713872 16485898 15968718 16177239 19164858 11743745 12153990 19420014 12392966 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
15.21 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
15.21 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
15.21 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
15.21 | 17522070 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.10 | 19426721 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.17 | 16402076 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.46 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.76 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.75 | 16134523 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.12 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
dibutylnitrosamine |
10.66 | 12706858 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
10.66 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
Nitrosamines |
10.66 | 12397637 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
10.66 | 15264214 15150132 15623463 15547733 16510608 15878914 16805852 16704527 15547721 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.65 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
18.65 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.65 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
18.65 | 19224547 16917069 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.13 | 12168785 12639820 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.68 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.52 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
8.72 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.72 | 19176532 18467677 19772884 16221962 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.68 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.16 | 20558911 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
11.80 | 16046005 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
11.80 | 17658665 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.09 | 10903974 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.39 | 15869954 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.13 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.13 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.62 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.75 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.75 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.21 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.21 | 12371664 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.94 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.81 | 20032147 18522880 18665156 18407596 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
2.58 | 15798949 15504291 17724770 15366600 18637143 17881167 17198567 15733078 16009107 17196135 18567088 18237412 16169303 16270385 17203207 16570917 14643895 15081153 18239293 15086199 15571005 15138612 17534399 15298665 15577212 15793283 15161499 17666798 15369754 15492853 14709902 18629640 17201889 18095165 15479170 16544323 17465448 15339415 14568256 15842777 16042886 15744066 15067225 12918455 15864749 18364076 14726149 17640959 17348192 15591649 15383259 18210741 18672772 17036385 15942678 15099470 16627068 15723089 12925901 14659978 17432682 17719030 16603200 18371158 15763062 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.58 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.89 | 19460945 16611625 12969438 11587558 19014921 12587719 19784758 16610002 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.89 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.61 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
9.61 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
dibutylnitrosamine |
10.79 | 15881669 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.79 | 20501860 19255062 20101389 19850985 21071580 21047994 2862719 20434301 18977376 19073162 19642983 15885732 15175105 19090486 18978307 21167192 19254457 2422723 20118626 20583210 18648771 19427195 19426721 19551842 20492335 19996281 12112319 16942905 19812893 10737359 21278145 19690152 19833225 19638242 19256749 20137499 19294768 18644402 12771043 9163691 20405173 19499222 18754104 20452335 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
10.79 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.79 | 15890375 20007298 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.17 | 17942915 3124819 16267830 17854601 18079962 16842330 18093689 21159647 19009564 18164116 19539802 18253720 18544905 18308698 18775883 18282651 19004024 19126423 2563599 9362446 19519916 17174075 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
6.17 | 15603536 6150874 1848544 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.70 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
2.70 | 16061637 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
2.85 | 11408345 17203775 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.55 | 19513568 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
3.94 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.39 | 19142101 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.49 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.13 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.93 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.85 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.56 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.94 | 17405874 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.78 | 9884423 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.27 | 19348381 18481113 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.12 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.12 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.12 | 20387270 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.68 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.68 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.41 | 12819281 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.52 | 17393432 16525653 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.37 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.41 | 16540662 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
5.43 | 11026799 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.88 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.88 | 2563599 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
5.40 | 10903871 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
4.17 | 15331141 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.38 | 19058328 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.85 | 18045962 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
2.73 | 20107430 20521326 16141801 11763009 18855531 17726453 20580759 17667964 11151749 20521320 19369910 20168265 18806925 17123785 20452607 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.52 | 18551238 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.27 | 16503802 15862959 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
5.27 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.51 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
3.51 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
3.51 | 17575124 12958204 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
2.97 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.88 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
dibutylnitrosamine |
5.88 | 12706858 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.31 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.96 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
4.64 | 18645019 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.98 | 1336536 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.45 | 17502770 20107430 20521320 20564506 16141801 16402076 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.07 | 17933447 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |